Association of Hepatitis-B virus infection status with survival and treatment response in non-small cell lung cancer patients on anti‐pd‐1/pd-l1 therapy

AIM: HBV reactivation is a significant risk for cancer patients undergoing immunosuppressive or chemotherapy. However, since these patients are often excluded from immunotherapy trials, the safety of anti-PD-1 and anti-PD-L1 therapies in this context remains unclear. Recent advances in cancer treatm...

Full description

Saved in:
Bibliographic Details
Main Authors: Eda Alp, Goncagul Akdag Topal, DENİZ IŞIK, Nedim Turan
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524004259
Tags: Add Tag
No Tags, Be the first to tag this record!